Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer (NSCLC)

NCT00654030 is registered in ClinicalTrials.gov with Edward Hirschowitz as lead sponsor.

NCT NCT00654030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00654030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer (NSCLC)
Lead sponsor
Edward Hirschowitz
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2006
Completion date
November 30, 2009
Enrollment
12 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer